Skip to main content
. 2013 Jul 18;8(9):1583–1590. doi: 10.2215/CJN.00550113

Table 4.

Prevalence ratios for aTRH associated with study covariates among REGARDS study participants with CKD

Characteristic Age, Race, and Sex Adjusted Multivariable Adjusteda
Age, per 10 yr 0.99 (0.93 to 1.05) 1.05 (0.98 to 1.13)
Women 0.75 (0.67 to 0.84) 0.87 (0.76 to 0.99)
Black race 1.56 (1.38 to 1.75) 1.49 (1.31 to 1.68)
Region
 Nonbelt 1 (ref) 1 (ref)
 Belt 1.03 (0.91 to 1.17) 1.04 (0.92 to 1.19)
 Buckle 1.04 (0.90 to 1.20) 1.05 (0.91 to 1.22)
Income<$20,000 1.18 (1.04 to 1.33) 1.08 (0.94 to 1.23)
Less than high school education 1.07 (0.93 to 1.23) 0.99 (0.85 to 1.15)
Waist circumference, per 15 cm 1.19 (1.13 to 1.25) 1.13 (1.07 to 1.20)
Diabetes 1.44 (1.29 to 1.62) 1.13 (1.00 to 1.28)
Current smoking 0.98 (0.83 to 1.16) 1.01 (0.85 to 1.20)
Alcohol use 0.95 (0.83 to 1.07) 1.02 (0.90 to 1.17)
Physical activity
 None 1 (ref) 1 (ref)
 1–3 times/wk 0.91 (0.80 to 1.04) 1.00 (0.88 to 1.14)
 4+ times/wk 0.79 (0.68 to 0.92) 0.90 (0.77 to 1.05)
History of myocardial infarction 1.34 (1.19 to 1.51) 1.20 (1.06 to 1.36)
History of stroke 1.23 (1.07 to 1.42) 1.15 (1.00 to 1.33)
Statin use 1.44 (1.29 to 1.62) 1.29 (1.14 to 1.46)
Total cholesterol, per 40 mg/dl 0.90 (0.84 to 0.95) 0.97 (0.91 to 1.04)
HDL cholesterol, per 15 mg/dl 0.86 (0.81 to 0.92) 0.95 (0.88 to 1.02)
C-reactive protein>3 mg/L 1.07 (0.96 to 1.20) 0.96 (0.86 to 1.08)
eGFR, ml/min per 1.73 m2
 ≥60 1 (ref) 1 (ref)
 45–59 0.95 (0.83 to 1.09) 1.18 (1.00 to 1.40)
 <45 1.25 (1.08 to 1.44) 1.22 (1.05 to 1.43)
ACR, mg/g
 <10 1 (ref) 1 (ref)
 10–29 1.44 (1.16 to 1.79) 1.32 (1.06 to 1.65)
 30–299 1.43 (1.20 to 1.70) 1.50 (1.22 to 1.83)
 ≥300 2.37 (1.97 to 2.85) 2.24 (1.83 to 2.76)

CKD was defined as an ACR≥30 mg/g or an eGFR<60 ml/min per 1.73 m2. Numbers are prevalence ratios (95% confidence intervals).

a

Adjusted for age, race, sex, geographic region, income, education, physical activity, current smoking, alcohol use, waist circumference, diabetes, total cholesterol, HDL cholesterol, statin use, C-reactive protein, history of myocardial infarction, history of stroke, ACR, and eGFR.